These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 861951)
1. A model for prediction of chemotherapy response to 5-fluorouracil based on the differential distribution of 5-[18F]fluorouracil in sensitive versus resistant lymphocytic leukemia in mice. Shani J; Wolf W Cancer Res; 1977 Jul; 37(7 Pt 1):2306-8. PubMed ID: 861951 [TBL] [Abstract][Full Text] [Related]
2. [Comparison of free ribonucleotide pool in the spleens of C57BL and DBA/2 mice and in leukemia cells sensitive and resistant to 5-fluorouracil]. Gerasimova GK; Mokina VD; Sidorova TA Biokhimiia; 1978 Jan; 43(1):163-9. PubMed ID: 623843 [TBL] [Abstract][Full Text] [Related]
3. The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia. Chadwick M; Rogers WI Cancer Res; 1972 May; 32(5):1045-56. PubMed ID: 4259631 [No Abstract] [Full Text] [Related]
4. [Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents]. Ninomiya K; Sekido S; Araki T Gan To Kagaku Ryoho; 1984 Jun; 11(6):1315-23. PubMed ID: 6428326 [TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of advanced L1210 leukemia with platinum compounds in combination with other antitumor agents. Gale GR; Atkins LM; Meischen SJ; Smith AB; Walker EM Cancer Treat Rep; 1977; 61(3):445-50. PubMed ID: 872142 [TBL] [Abstract][Full Text] [Related]
6. Response of drug-sensitive and -resistant L1210 leukemias to high-dose chemotherapy. Griswold DP; Trader MW; Frei E; Peters WP; Wolpert MK; Laster WR Cancer Res; 1987 May; 47(9):2323-7. PubMed ID: 3567926 [TBL] [Abstract][Full Text] [Related]
7. Inability of amphotericin B(Fungizone) or of sodium deoxycholate to alter natural drug resistance or sensitivity of transplanted murine leukemias. Ganu UK; Khandalekar DD; Gokhale SV Indian J Physiol Pharmacol; 1984; 28(1):21-6. PubMed ID: 6490126 [TBL] [Abstract][Full Text] [Related]
8. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model. Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182 [TBL] [Abstract][Full Text] [Related]
9. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents. Chou TC; Schmid FA; Feinberg A; Philips FS; Han J Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591 [TBL] [Abstract][Full Text] [Related]
10. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations. Kim K; Blechman WJ; Riddle VG; Pardee AB Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006 [TBL] [Abstract][Full Text] [Related]
11. Transport of melphalan by sensitive and resistant L1210 cells. Redwood WR; Colvin M Cancer Res; 1980 Apr; 40(4):1144-9. PubMed ID: 7357545 [No Abstract] [Full Text] [Related]
12. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines. Mulcahy RT; Siemann DW Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329 [TBL] [Abstract][Full Text] [Related]
13. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [TBL] [Abstract][Full Text] [Related]
14. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells. Watanabe M; Komeshima N; Nakajima S; Tsuruo T Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075 [TBL] [Abstract][Full Text] [Related]
15. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799 [TBL] [Abstract][Full Text] [Related]
16. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil. Klubes P; Cerna I Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628 [TBL] [Abstract][Full Text] [Related]
17. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia. Schmid FA; Hutchison DJ; Otter GM; Stock CC Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516 [TBL] [Abstract][Full Text] [Related]
18. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine. Li ZR; Campbell J; Rustum YM Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558 [TBL] [Abstract][Full Text] [Related]
19. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo. Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375 [TBL] [Abstract][Full Text] [Related]
20. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo]. Kukushkina GV; Peretolchina NM; Minenkova EA; VerovskiÄ VN; Sof'ina ZP Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]